Lenalidomide-Epoetin Alfa Versus Lenalidomide Monotherapy in Myelodysplastic Syndromes Refractory to Recombinant Erythropoietin
National Cancer Institute (NCI)
Alan F List; Zhuoxin Sun; Amit Verma; John M Bennett; Rami S Komrokji; Kathy McGraw; Jaroslaw Maciejewski; Jessica K Altman; Puneet S Cheema; David F Claxton; Selina M Luger; Ryan J Mattison; Timothy R Wassenaar; Andrew S Artz; Charles A Schiffer; Mark R Litzow; Martin S Tallman
Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA.